NEWRON PHARMACEUT. EO-20 (NP5) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.119x

Based on the latest financial reports, NEWRON PHARMACEUT. EO-20 (NP5) has a cash flow conversion efficiency ratio of 0.119x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.33 Million ≈ $-1.55 Million USD) by net assets (€-11.13 Million ≈ $-13.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NP5 equity to assets ratio to measure how much of total assets are equity-financed.

NEWRON PHARMACEUT. EO-20 - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how NEWRON PHARMACEUT. EO-20's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NEWRON PHARMACEUT. EO-20 earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

NEWRON PHARMACEUT. EO-20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NEWRON PHARMACEUT. EO-20 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Surya Permata Andalan Tbk PT JK:NATO	0.005x
CODERE ONLINE LUX. EO 1 F:J9T	N/A
Hana Tour KO:039130	0.120x
Bunker Hill Mining Corp. V:BNKR	0.098x
High Liner Foods Incorporated TO:HLF	-0.061x
Armata Pharmaceuticals Inc NYSE MKT:ARMP	0.031x
Inmobiliaria del Sur SA MC:ISUR	0.166x
Vox Royalty Corp. TO:VOXR	0.024x

Annual Cash Flow Conversion Efficiency for NEWRON PHARMACEUT. EO-20 (2005–2025)

The table below shows the annual cash flow conversion efficiency of NEWRON PHARMACEUT. EO-20 from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of NEWRON PHARMACEUT. EO-20.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-11.13 Million ≈ $-13.01 Million	€32.56 Million ≈ $38.07 Million	-2.926x	+75.78%
2024-12-31	€1.46 Million ≈ $1.70 Million	€-17.61 Million ≈ $-20.59 Million	-12.081x	-3663.28%
2023-12-31	€-29.91 Million ≈ $-34.97 Million	€-10.14 Million ≈ $-11.85 Million	0.339x	-57.12%
2022-12-31	€-14.03 Million ≈ $-16.40 Million	€-11.09 Million ≈ $-12.97 Million	0.791x	+121.46%
2021-12-31	€3.11 Million ≈ $3.63 Million	€-11.45 Million ≈ $-13.38 Million	-3.684x	-307.54%
2020-12-31	€17.25 Million ≈ $20.16 Million	€-15.59 Million ≈ $-18.22 Million	-0.904x	-51.35%
2019-12-31	€36.80 Million ≈ $43.02 Million	€-21.98 Million ≈ $-25.69 Million	-0.597x	-105.27%
2018-12-31	€54.84 Million ≈ $64.11 Million	€-15.95 Million ≈ $-18.65 Million	-0.291x	-134.45%
2017-12-31	€67.72 Million ≈ $79.17 Million	€-8.40 Million ≈ $-9.83 Million	-0.124x	+68.48%
2016-12-31	€49.75 Million ≈ $58.16 Million	€-19.58 Million ≈ $-22.89 Million	-0.394x	-13.58%
2015-12-31	€37.11 Million ≈ $43.39 Million	€-12.86 Million ≈ $-15.04 Million	-0.347x	-1.43%
2014-12-31	€29.26 Million ≈ $34.21 Million	€-10.00 Million ≈ $-11.69 Million	-0.342x	+32.56%
2013-12-31	€21.09 Million ≈ $24.66 Million	€-10.69 Million ≈ $-12.49 Million	-0.507x	-340.15%
2012-12-31	€27.61 Million ≈ $32.28 Million	€5.83 Million ≈ $6.81 Million	0.211x	+128.11%
2011-12-31	€6.58 Million ≈ $7.70 Million	€-4.94 Million ≈ $-5.78 Million	-0.750x	+52.17%
2010-12-31	€12.19 Million ≈ $14.25 Million	€-19.13 Million ≈ $-22.36 Million	-1.569x	-99.27%
2009-12-31	€29.28 Million ≈ $34.23 Million	€-23.06 Million ≈ $-26.95 Million	-0.787x	-80.96%
2008-12-31	€45.81 Million ≈ $53.56 Million	€-19.93 Million ≈ $-23.30 Million	-0.435x	-80.11%
2007-12-31	€57.40 Million ≈ $67.11 Million	€-13.87 Million ≈ $-16.21 Million	-0.242x	-70.22%
2006-12-31	€67.86 Million ≈ $79.33 Million	€-9.63 Million ≈ $-11.26 Million	-0.142x	+83.14%
2005-12-31	€17.02 Million ≈ $19.90 Million	€-14.33 Million ≈ $-16.75 Million	-0.842x	--

About NEWRON PHARMACEUT. EO-20

XETRA:NP5 Germany Biotechnology

Market Cap

$306.87 Million

€262.49 Million EUR

Market Cap Rank

#14634 Global

#1461 in Germany

Share Price

€13.15

Change (1 day)

+0.77%

52-Week Range

€7.16 - €32.55

All Time High

€32.55